Skip to main content
    I

    iRhythm Technologies Inc (IRTC)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $90.83
    -1.08 (-1.18%)

    Market Cap: $3.05B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    iRhythm Technologies Inc (IRTC) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    iRhythm Technologies (IRTC) trades at 74.5x trailing earnings and 3.5x sales. Its P/S of 3.5x is below its 5-year median of 6.9x. Its forward P/E is 54.6x. The median P/E across 9 similar companies is 23.9x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 36.4% higher over the next year. Its free cash flow yield is 0.2%.

    MultipleValue
    P/E (trailing)74.5x
    Forward P/E54.6x
    Price to sales3.5x
    Price to book17.0x
    Price to FCF407.3x
    EV/FCF442.2x
    PEGN/A
    FCF yield0.2%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 57.8% below 8.3x and its P/B is 9.6% below 18.8x.

    MultipleCurrent5-year median10-year median
    P/S3.5x6.9x8.3x
    P/B17.0x21.0x18.8x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 119 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/S ranged from 2.1x in 2016 to 24.9x in 2020.

    Year endPriceP/SP/B
    2025$177.447.7x38.7x
    2024$90.174.8x31.1x
    2023$107.046.6x15.6x
    2022$93.676.8x11.8x
    2021$117.6910.7x12.4x
    2020$237.2124.9x20.1x
    2019$68.098.0x13.4x
    2018$69.4811.3x31.0x
    2017$56.0512.8x16.3x
    2016$30.002.1x5.4x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About IRTC

    What is IRTC's forward P/E ratio?

    iRhythm Technologies has a forward P/E ratio of 54.6x.

    Is IRTC stock overvalued?

    GNG's valuation label for IRTC is Undervalued. Its P/E of 74.5x compares with a median of 23.9x across 9 similar companies.

    What is IRTC's price to sales ratio?

    iRhythm Technologies has a price to sales ratio of 3.5x.